Regulation of NLRP3 by non-coding RNAs in different cancers: interplay between non-coding RNAs and NLRP3 in carcinogenesis and metastasis
- PMID: 34174977
Regulation of NLRP3 by non-coding RNAs in different cancers: interplay between non-coding RNAs and NLRP3 in carcinogenesis and metastasis
Abstract
NLRP3 (NOD-, LRR- and pyrin domain-containing protein 3) inflammasomes are multitasking intracellular sensors having characteristically unique ability to detect myriad of microbial motifs and endogenous danger signals which promote structural assembly of NLRP3 inflammasome thus enabling it to perform instrumental roles. Detailed mechanistic insights revealed that molecularly assembled NLRP3 inflammasomes stimulated caspase-1-driven release of the pro-inflammatory cytokines. NLRP3 has been shown to play fundamental role in the regulation of cancer progression and metastasis. Recently emerging cutting-edge research-works have started to shed light on the involvement of non-coding RNAs in the regulation of NLRP3 in different cancers. MicroRNAs, lncRNAs and circular RNAs have been shown to modulate NLRP3 in different diseases. However, we still have incomplete information about regulation of NLRP3 by circular RNAs in various cancers. In this review, we will comprehensively analyze how different microRNAs and long non-coding RNAs modulate NLRP3 in human cancers. Emerging evidence has started to scratch the surface of the participation of miRNAs and lncRNAs in the regulation of NLRP3. Xenografted mice-based studies have also enabled us to develop a better comprehension of interplay between miRNAs, lncRNAs and NLRP3. Hopefully, detailed analysis of contextual regulation of NLRP3 by oncogenic and tumor suppressor miRNAs, lncRNAs and circRNAs will be helpful in getting a step closer to the personalized medicine.
Keywords: Molecular cancer; NLRP3; Non-coding RNA.; Signaling.
Similar articles
-
Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases.Int Immunopharmacol. 2021 Nov;100:108105. doi: 10.1016/j.intimp.2021.108105. Epub 2021 Sep 1. Int Immunopharmacol. 2021. PMID: 34481143 Review.
-
Functional crosstalk between Long non-coding RNAs and the NLRP3 inflammasome in the regulation of diseases.Mol Immunol. 2021 Mar;131:191-200. doi: 10.1016/j.molimm.2020.12.038. Epub 2021 Jan 11. Mol Immunol. 2021. PMID: 33446392 Review.
-
The Association between the NLRP3 Inflammasome and Specific Long-Non Coding RNAs (lncRNAs) in Cancer; New Perspective and Summary of Recent Studies.Cell Biochem Biophys. 2025 Mar;83(1):147-158. doi: 10.1007/s12013-024-01494-4. Epub 2024 Sep 16. Cell Biochem Biophys. 2025. PMID: 39285156 Review.
-
NLRP3 inflammasome pathway in atherosclerosis: Focusing on the therapeutic potential of non-coding RNAs.Pathol Res Pract. 2023 Jun;246:154490. doi: 10.1016/j.prp.2023.154490. Epub 2023 Apr 25. Pathol Res Pract. 2023. PMID: 37141699 Review.
-
The Long Non-coding RNAs: Paramount Regulators of the NLRP3 Inflammasome.Front Immunol. 2020 Sep 25;11:569524. doi: 10.3389/fimmu.2020.569524. eCollection 2020. Front Immunol. 2020. PMID: 33101288 Free PMC article. Review.
Cited by
-
Molecular basis of acute coronary syndrome.J Res Med Sci. 2022 May 30;27:40. doi: 10.4103/jrms.jrms_695_21. eCollection 2022. J Res Med Sci. 2022. PMID: 35968216 Free PMC article. Review.
-
Circular RNA ZNF609 drives tumor progression by regulating the miR-138-5p/SIRT7 axis in melanoma.Aging (Albany NY). 2021 Aug 9;13(15):19822-19834. doi: 10.18632/aging.203394. Epub 2021 Aug 9. Aging (Albany NY). 2021. Retraction in: Aging (Albany NY). 2024 May 15;16(9):8399. doi: 10.18632/aging.205843. PMID: 34370715 Free PMC article. Retracted.
-
Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy.Int J Mol Sci. 2023 Feb 7;24(4):3245. doi: 10.3390/ijms24043245. Int J Mol Sci. 2023. PMID: 36834660 Free PMC article. Review.
-
Emerging Role of LncRNA Regulation for NLRP3 Inflammasome in Diabetes Complications.Front Cell Dev Biol. 2022 Jan 12;9:792401. doi: 10.3389/fcell.2021.792401. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35087834 Free PMC article. Review.
-
Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer.Discov Oncol. 2023 Jun 10;14(1):93. doi: 10.1007/s12672-023-00701-7. Discov Oncol. 2023. PMID: 37300757 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical